Clinical Trials — Gynecologic Cancer

Click on trial for description and contact information.

Click for contact information on Phase III trials.

 

• Study of XL184 in Adults with Advanced Solid Tumors   
   
   
• Study of XL147 in Advanced or Recurrent Endometrial Cancer
   

 

For more information or to refer a patient, contact:

Pam Bourbo, RN, MPH, OCN, CCRC
Manager Cancer Center Clinical Trials Office & Cancer Clinical Research Unit (CCRU)
MCGHealth Cancer Clinical Center
AN - 2108
1411 Laney Walker Blvd.

Office: (706) 721-2730
pbourbo@georgiahealth.edu

 

  Phase III Clinical Trials for Gynecologic Cancer are available. 

 

• GOG 0213 clinical trial in Ovarian, Peritonerimary and Fallopian Tube Cancer
• GOG 0240 clinical trial of Recurrent or Persistent Carcinoma of the Cervix
• GOG 0250 clinical trial of Recurrent Advanced Leiomyosarcoma of the Uterus
• GOG 0261 clinical trial of Recurrent or Persistent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus or Ovary.
• GOG 0136 clinical trial of the acquisition of human gynecologic specimens and serum to be used in studying the cases, diagnosis, prevention and treatment of cancer.

 

For more information, contact:

• Steven McKinnon, RN
• Sara Mobley, RN, BSN, OCN
• Donna Wheatley, LPN

Office: (706) 721-5557